drug

eltrekibart

1 story · latest Oct 9, 2026

Follow eltrekibart. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: Investigational
Code: LY3041658
Trials: 3 registered trials in coverage

Relationships

Developed by Eli Lilly

Timeline

Lilly advances obesity and inflammation pipeline with new Phase 1 trials, Phase 2 updates

Oct 9Weekly roundup, 10 itemsEli Lilly eloralintide

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.